Table 1.
Clinical characteristics of plaque psoriasis patients and control subjects.
| Patient Characteristics | Control n = 60 |
PN n = 30 |
PH n = 30 |
|
|---|---|---|---|---|
| Sex | Male n (%) | 23 (38.33%) | 13 (43.33%) | 10 (33.33%) |
| Female n (%) | 37 (61.67%) | 17 (56.67%) | 20 (66.67%) | |
| Age (years) | 52 ± 5 | 49 ± 6 | 51 ± 3 | |
| Height (cm) | 172 ± 6 | 176 ± 3 | 169 ± 8 | |
|
Weight (kg)
Duration of psoriasis (years) |
75 ± 1 | 72 ± 3 | 74 ± 1 | |
| ND | 9.7 ± 3.4 | 18.52 ± 7.8 | ||
| PASI | ND | 10.39 ± 2.4 | 18.29 ± 4.6 | |
| Psoriasis in the family | <1 n (%) | ND | 18 (60%) | 6 (20%) |
| ≥1 n (%) | ND | 12 (40%) | 24 (80%) | |
| Blood Tests | ||||
| RBC (106/µL) | 4.54 ± 0.54 | 4.23 ± 0.65 | 4.89 ± 0.87 | |
| HCT (%) | 40.25 ± 6.5 | 42.45 ± 4.25 | 45.21 ± 0.89 | |
| PLT (103/µL) | 275 ± 56 | 245 ± 87 | 292 ± 23 | |
| WBC (103/µL) | 6.5 ± 2.2 | 7.05 ± 1.8 | 6.98 ± 1.86 | |
| CRP (mg/L) | 1.5 ± 0.5 | 8.56 ± 6.3 | 6.32 ± 7.56 | |
| Glc (mg/dL) | 69 ± 9.8 | 72 ± 9.8 | 75 ± 6.5 | |
| ALT (U/L) | 27.56 ± 12.3 | 24.36 ± 9.68 | 27.24 ± 6.35 | |
| AST (U/L) | 28.54 ± 12.25 | 30.23 ± 6.52 | 28.98 ± 8.64 | |
| Dental Characteristics | ||||
| DMFT | 20 ± 3 | 19 ± 6 | 21 ± 2 | |
| GI | 0.2 ± 0.1 | 0.2 ± 0.2 | 0.1 ± 0.2 | |
| PPD | 1.5 ± 0.5 | 1.0 ± 0.5 | 1.0 ± 0.5 | |
| Dental implants | 0 | 0 | 0 | |
Abbreviations: ALT—alanine transferase; AST—aspartate transaminase; CRP—C-reactive protein; DMFT—decayed, missing, filled teeth index; GI—gingival index; Glc—D-glucose; HCT—hematocrit; n—number of patients; PASI—Psoriasis Area and Severity Index; PBI—papilla bleeding index; PLT—platelets; RBC—red blood cells; WBC—white blood cells. ND- not defined.